Related Experiment Videos
Hypnotic effects of deoxycorformycin in rats.
Brain Research
|July 25, 1983
Summary
Deoxycoformycin, an adenosine deaminase inhibitor, altered sleep patterns in rats. Lower doses increased REM sleep, while higher doses promoted deep slow-wave sleep, suggesting adenosine
Area of Science:
- Neuroscience
- Pharmacology
- Sleep Research
Background:
- Adenosine is a neuromodulator implicated in regulating sleep-wake cycles.
- Adenosine deaminase (ADA) is an enzyme that metabolizes adenosine.
- Inhibiting ADA can increase central nervous system adenosine levels.
Purpose of the Study:
- To investigate the effects of deoxycoformycin, a potent ADA inhibitor, on sleep architecture in rats.
- To explore the potential hypnotic role of adenosine in the central nervous system.
Main Methods:
- Rats were surgically implanted with electroencephalogram (EEG) and electromyogram (EMG) electrodes.
- Animals received intraperitoneal injections of deoxycoformycin at doses of 0.5 mg/kg or 2.0 mg/kg.
- Polygraphic recordings were conducted for 6 hours post-administration.
Main Results:
- The 0.5 mg/kg dose of deoxycoformycin significantly increased Rapid Eye Movement (REM) sleep and reduced REM sleep latency.
- The 2.0 mg/kg dose of deoxycoformycin led to an increase in deep slow-wave sleep (S2).
- These findings align with previous studies using adenosine analogs like N6-(L-phenylisopropyl)-adenosine (L-PIA).
Conclusions:
- Deoxycoformycin administration differentially affects sleep stages in a dose-dependent manner.
- The results support a role for endogenous adenosine in promoting both REM sleep and deep slow-wave sleep.
- Adenosine acts as a hypnotic agent within the central nervous system.